INTRODUCTION
Only a fraction of those who need care for mental or substance-use conditions receive treatment, in part, because their need for services is not recognized 1, 2 . Even among those who eventually seek treatment, the median delay from symptom onset to help-seeking is 6 years for alcohol dependence, 8 years for major depression, and 9 years for generalized anxiety disorder 3 . Screening is a key first step to identify individuals with mental or substance-use conditions who often do not perceive their need for help so that they can be offered treatment. There is a growing emphasis on the role of primary care practitioners in addressing behavioral health problems, and screening for mental and substance-use conditions is one important strategy that primary care practitioners can use to improve problem recognition and shorten the time to start of treatment 4 .
A strategy of screening in primary care settings is fruitful for three reasons: First, primary care practitioners have access to a large segment of the population; in 2001, 68% of adults reported an appointment for routine care within the past year 5 . Second, numerous screening instruments are available. A voluminous literature supports the validity and reliability of mental and substance-use condition screening tools (e.g., AUDIT for alcohol or Zung for depression) and their sensitivity and specificity are equivalent to those used to detect somatic problems 6 . Standard screening questionnaires specifically designed to detect these conditions improve problem detection. Screening questions can be asked as a stand-alone risk assessment or embedded in a general health questionnaire, administered by a practitioner or completed by the patient, and are valuable both in a targeted population and as a universal program. Third, screening is clearly only a first step. While screening alone has not been shown to improve outcomes, screening combined with appropriate interventions has demonstrated benefit [7] [8] [9] . For instance, a screening and brief intervention trial for problem drinkers demonstrated a 30% risk reduction for excessive drinking in the past week after 12 months and 20% fewer emergency department visits after 4 years 10, 11 . Moreover, a recent review showed that collabora-tive care, including screening, for depression is effective in improving outcomes 12, 13 .
Despite sound clinical rationale, many primary care practitioners do not screen using standard questionnaires nor do they talk with their patients about emotional problems or substance abuse. A national study reported that among adult primary care patients, 28% had discussed drinking or drug use, and 21% had been asked about depression or anxiety symptoms during routine health visits within the past year 14, 15 . Moreover, providers often fail to consider mental or substance-use conditions in the list of possible problems when patients present with physical complaints 16, 17 .
Low screening levels are inconsistent with the recommendations of expert panels. In 2002, the United States Preventive Services Task Force (USPSTF) recommended depression screening for adults in practices that have systems in place for appropriate continuing care 18 . While USPSTF has not revisited their neutral stance on screening for drug problems from the second edition, in 2004, they reaffirmed a recommendation for alcohol misuse screening 9, 18, 19 . The gap between current clinical recommendations and present practices is not unique to mental health and substance-use condition screening. For instance, McGlynn and colleagues found that patients received only 52% of all recommended screening services (across a spectrum of medical conditions) for which they were eligible 20 .
One potentially effective approach to closing this gap is to have health plans require the recommended service 21 Typically, there were two respondents per plan (executive director for the administrative module and medical director for the clinical module, or their designees). For some national or regional plans, we interviewed respondents at corporate headquarters regarding multiple sites, and some plans referred us to their behavioral health vendor for questions regarding specialty services. Items were asked at the product level within each market-area-specific health plan. Data collection methods were similar for 1999 and 2003. Notwithstanding our high response rates, we conducted a nonresponse analysis; responding plans were slightly less likely to offer only PPO products.
The study is linked to the Community Tracking Study (CTS), a longitudinal study of health system change, funded by the Robert Wood Johnson Foundation 23 . The CTS sample design contained strata for large metropolitan, small metropolitan, and nonmetropolitan market areas. Within strata, nearly all sites were randomly selected with probability proportional to size (a few sites selected with certainty). The primary sampling units for our survey were the 60 market areas selected for the CTS to be nationally representative. Our second sampling stage consisted of selecting health plans within market areas. Plans serving multiple markets were defined as separate plans for the study, and data were collected with reference to the market area. Sample selection is depicted in Figure 1 .
We categorized products as HMO, POS, or PPO. Contracting arrangements include products with specialty managed behavioral healthcare organization (MBHO) contracts, with comprehensive (combined general medical and behavioral health) contracts, and with internal-only provision (services provided by health plan employees or through a network directly administered by the plan). In addition to survey data, we used 2003 Census Bureau data to estimate market area population and mapped our sites to aggregated Census region 24 .
Screening Measures
The clinical module included items regarding screening by primary care practitioners for mental health, alcohol, and drug problems. For each insurance product, we assessed whether products required primary care providers to use a general health screening by asking, "Under (product), are primary care practitioners required to use general health screening questionnaires that include questions about mental health problems, alcohol problems, or drug problems?" We also asked "Under (product), are primary care practitioners required to use standard screening questionnaires specifically designed to detect (condition) among at least some of their patients?" to determine if products required the use of a specific instrument.
Respondents were asked about specific screening of mental health problems, alcohol problems, and drug problems separately and were cued with the names of specific screening instruments if needed. In our analysis, we judged a product to have any behavioral health screening requirement if it reported either a general screening requirement or any specific screening requirement for mental health, alcohol, or drug problems. We did not ask which specific instrument plans required, whether plans reimburse for screening, if plans provide questionnaires, or how these requirements impacted provider behavior.
Statistical Analysis
The data are weighted and represent national estimates of health plans' private insurance products in the continental United States. Statistical analyses were implemented using SUDAAN software to allow accurate estimation of the sampling variance given our complex sampling design 25 . We used t-tests to compare estimates across years. We also constructed four logistic regression models. The first model, which includes all products, has, as its dichotomous dependent variable, any (general or specific) required screening. The other three models, conditional on requiring any screening, predict whether required screening is general only or involves specific screening (specific only or specific plus general), with separate models for mental health, alcohol, and drug abuse screening. Key explanatory variables in all models are listed in Table 1 and include product type, contracting arrangement, tax status, region, and market area population.
Sample Characteristics
Sample characteristics are described in Table 1 . In 1999, HMO products were most common (40.6%) followed by PPO and POS products. In 2003, the product types were closer to equal thirds, although POS plans were slightly more prevalent. Contracting with a specialty MBHO predominated, increasing from 59.8% in 1999 to 72.7% in 2003. 
RESULTS

Change in Screening Requirements
From 1999 to 2003, the proportion of insurance products with any behavioral health screening requirements remained largely unchanged with 34.0% of products requiring some type of screening for mental health, alcohol, or drug abuse in 2003 (Table 2 ). Among products with any behavioral health screening requirement, the proportion requiring the use of a specific mental health screening instrument decreased from 29.5% in 1999 to 14.4% in 2003. In contrast, the proportion requiring specific screening for alcohol or drug problems increased to over three-quarters of products. When products require a specific screen, they almost always also require general screening (data not shown). Product type was strongly associated with the change in prevalence of screening requirements (Table 3) . From 1999 to 2003, PPO products appear to have caught up with their HMO and POS counterparts in the proportion requiring screening. The percentage of PPO products with any behavioral health screening requirement went from 18.7 to 34.4%. HMO products had a decrease, and POS products did not have a significant change in behavioral health screening requirements. Among those products with a behavioral health screening requirement, all product types demonstrated significant increases in the percent requiring specific instruments for alcohol and drugs, while POS products showed significant decreases in requiring specific mental health screening.
Among products with specialty contracting, requirements for behavioral health screening increased among those with specialty contracts and decreased among those with comprehensive contracts. Among those products with a behavioral health screening requirement, both products with specialty contracts and those with internal management showed increased requirements for a specific screen for alcohol and drugs from 1999 to 2003.
Predictors of Screening Requirements
Predictors of any screening requirement in 2003 included product type, contracting arrangement, and region according to our multivariate models. POS products were less likely than HMOs (OR=0.69 95%, CI=0.47-1.00) to have any screening requirement when controlling for plan type, tax status, region, and market size (Table 4) . Products with a behavioral health specialty contract were much more likely to have a screening requirement than those with internal arrangements (OR=3.67 95%, CI=1.59-8.45), and those with comprehensive contracting were much less likely to have any screening requirement (OR=0.28 95%, CI=0.09-0.93). Products in the Midwest were the most likely to require any screening. Tax status and market area population variables were not significant.
In the regressions predicting specific mental health, alcohol, and drug abuse screening requirements (conditional on having any screening), product type predicted specific screening requirements: PPO and POS products were more likely to have specific alcohol or drug screening requirements than HMOs, and PPOs were more likely to require specific mental health screening. Products with a specialty contract were much less likely than those with internal arrangements to require the use of a specific screen. Other characteristics that predicted having a specific mental health screening requirement were nonprofit tax status and a market size of 1-2 million people. For alcohol and drug specific screening, for-profit products were much more likely to require a specific screen. Northeast or Midwest region also was associated with lower likelihood of specific alcohol or drug screening requirements among products with any screening requirement. . This represents a missed opportunity to improve identification of mental and substance-use conditions and encourage practice patterns that are adherent with evidence-based guidelines. Establishing standards for acceptable practice consistent with the recommendations of government panels and professional organizations is an important first step in improving prompt identification of mental and substance-use conditions.
Influences on Screening Requirements
Health plans may have been reluctant to require screening for mental and substance-use conditions for several reasons. First, conducting screening is difficult to monitor, in part, because substance-use screening procedures only recently have had procedure codes adopted. Currently, tracking the delivery of mental and substance-use condition screening would require chart review or patient surveys rather than less costly administrative data analysis. Moreover, chart review and patient surveys might underestimate screening because providers might not document negative screens and patients may not recall what questions they were asked. Second, health plans may consider screening requirements an unnecessary burden to place on primary care practitioners with whom they must maintain a working relationship. Health plans already enforce rules for claims submission, referral networks, and formularies. Specifying patterns of practice may be perceived as excessive management. Third, plans may not view primary care practitioners as gatekeepers to the behavioral health services sector. In contrast to their policies for referring somatic complaints, health plans often establish call centers for behavioral health that are independent of primary care.
One might anticipate that more plans will require screening in the future. In 2004, the National Committee for Quality Assurance (NCQA) introduced a new measure, identification of alcohol and other drug services 26 . Health plans motivated to improve their performance in the NCQA's high-visibility system of quality performance may turn to primary care providers to enhance their screening efforts. Moreover, the recent Institute of Medicine report on the quality of care for mental and substance-use conditions highlights the need for greater integration between general medical and specialty mental health service sectors 4 . Other changes affect primary care providers more directly and may help to make mental health and substance-use condition screening a sustainable and widely-diffused preventive service. The addition and utilization of procedure codes for alcohol and other drug screening would allow screening to be tracked through claims data and provide a mechanism for reimbursement. In addition, at least one large insurer has instituted incentive payments to primary care practitioners for performing depression screening in the context of a disease management program. The requirement for specific screening also changed from 1999 to 2003 with a decrease for mental health and increase for alcohol and drugs in the proportion of products requiring a specific screening questionnaire. A large body of literature supports the validity of specific instruments such as CAGE or AUDIT 7 . Moreover, government agencies have promoted screening and brief intervention as a mechanism to improve detection and reduce morbidity and mortality from excessive drinking 27 . Several studies have demonstrated that standard screening questionnaires have significantly better sensitivity over less formal means of problem recognition 6 . Recent clinical practice guidelines have sought to maintain specific screening, while reducing the burden it imposes. In 2005, the National Institute on Alcohol Abuse and Alcoholism recommended screening with one question, reducing the time required to fit screening into brief primary care visits 28 . The decrease in specific mental health screening may represent a shift toward embedding screening in general health questionnaires, but our data do not permit this type of analysis.
On the face of it, health plans seem to have required specific screens for alcohol and drugs. It is possible, however, that general screening questionnaires incorporate specific screening instruments. Standardized instruments such as the AUDIT can be appropriately incorporated into a broader questionnaire 29 , and self-reporting on consumption may be enhanced when alcohol questions are embedded in a general context 30 . Our data do not allow us to determine if general screening questionnaires include "ad hoc" questions with a specific screening instrument used as a complement or if an entire specific screening instrument is embedded in the general questionnaire.
Products with specialty behavioral health contracts were more likely to have any screening and less likely to have specific screening requirements than products with internal behavioral health services. Multiple reasons for this finding are plausible. First, contracting with a specialty organization may reflect a greater focus on behavioral health and more interest in identifying people with these problems. MBHOs have specialized expertise, designated resources, systems to ensure that patients get to the right providers, and specific programs for users of drugs and alcohol. Plans may believe that primary care practitioners will be more amenable to screening when it is clear where to refer patients who need specialized help. Second, health plans with specialty contracts frequently have capitated contracts 31 and may seek more actively to identify enrollees with behavioral health problems in order to refer them to the specialty vendor who is being paid to provide needed services on a population basis. At the same time, concerns have been raised that contracting with MBHOs may further separate behavioral health care from other medical care. However, little is known about the extent to which this arrangement typically affects the already existing fragmentation of care.
As noted in the Institute of Medicine report on crossing the quality chasm in behavioral health care, there is a significant need for improved detection, diagnosis, and assessment in both general medical and specialty behavioral health settings 4 .
Increasing the use of standardized instruments and improving the effectiveness of dissemination activities to increase "uptake" of evidence-based practices is an essential first step. Our study found that an increasing proportion of health plans are requiring mental health and substance use screening in primary care, suggesting a growing emphasis on this area of practice. However, two-thirds of plans still do not. Future research should explore factors that influence adoption of screening requirements, how health plans monitor and enforce such requirements (Granick et al., 2007, manuscript under review), and-perhaps most importantly-effects on actual clinical practice when requirements are implemented.
